Decision Diagnostics Corp (DECN)

[HFM2]

Did anyone talk to the SEC? I did.

- They can't talk about ongoing investigations . . .

- Noted that I would like for them to consider more than rumors and accusations against the company, to visit with Mr. Berman, et.al. and look closely at what was said and what was not said.

- I noted a concern that this may be a malicious short attack (not just shorting the stock) to deprive the company of a lucrative place in the COVID-19 solution community. Look closely.

I operate on two assumptions:

1. The SEC contacted DECN and Berman BEFORE suspending the stock (they neither confirmed nor denied), to which a corollary is that Berman knew about possibility of the upcoming suspension when he released the PR yesterday . . . (there is much to tease out of THAT).
2. The SEC does thorough and full investigations of the entire web of potential causes for accusations.

Some things come from these assumptions.

If the SEC had NOT contacted Berman before suspension, well . . . how is that a thorough investigation based apparently on the public record? How could reliance upon the stated public texts be properly vetted, especially since the lofty sales numbers were moderated considerably over the last month and anyone who was reading them had an opportunity to act on the information?

What did Berman mean by "technology perfected"? Is that made clear in any other document? If they can do it, but later on it is improved, was he lying? If so, why does this "improvement" not apply to any other improvement? So much parsing needed.